Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia: an Observational, Non-interventional Study

NCT03130465 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Europe Ltd as lead sponsor.

NCT NCT03130465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03130465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia: an Observational, Non-interventional Study
Lead sponsor
Otsuka Pharmaceutical Europe Ltd
Phase
Observational
Overall status
Unknown status
Start date
July 13, 2017
Completion date
January 31, 2020
Enrollment
636 (estimated)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia